13F Insight

Krognes Steve E.

CIK: 0001666236
Primary company: Guardant Health, Inc. (GH)

Krognes Steve E. is a corporate insider at Guardant Health, Inc. (GH) filing SEC Form 4 transactions. 169 transactions across 5 companies, totaling $0 in purchases and $15,192,415 in sales. Source: SEC EDGAR.

AI Insider Summary

Steve Krognes runs a two-directional biotech-board record: a Guardant Health (GH) sale of 9,294 shares at $132.51, set against Denali Therapeutics (DNLI) awards of 19,226 and 6,408 shares near $19.66. A small Corvus (CRVS) tie completes a multi-company director profile.

The contrast is the story — harvesting a higher-priced GH position while accumulating DNLI grants at a low-$20s level — with a smaller Corvus (CRVS) association rounding out a serial-director profile.

For readers, Krognes is a multi-board biotech insider whose net signal is mixed: GH selling at $132 versus DNLI accumulation near $20, rather than a one-way bet.

Total Transactions
169
Total Buy Value
$0
Total Sell Value
$15.19M
Net Activity
$-15.19M
Last Transaction
Jul 2026
Companies
5

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Exercise
Shares
155
Price
-
Value
-
Type
Exercise
Shares
155
Price
-
Value
-
Type
Award
Shares
2,711
Price
-
Value
-
Type
Exercise
Shares
4,203
Price
-
Value
-
Type
Exercise
Shares
4,203
Price
-
Value
-
Type
Sale
Shares
9,294
Price
$132.51
Value
$1.23M
Type
Award
Shares
19,226
Price
$19.66
Value
$378K
Type
Award
Shares
6,408
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
155
Price
-
Value
-
Type
Exercise
Shares
155
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
155
Price
-
Value
-
Type
Exercise
Shares
155
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-
Type
Exercise
Shares
154
Price
-
Value
-